Lupus nephritis - who class IV

Clinical trials for Lupus nephritis - who class IV explained in plain language.

Never miss a new study

Get alerted when new Lupus nephritis - who class IV trials appear

Sign up with your email to follow new studies for Lupus nephritis - who class IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1 Terminated 2

Immune cell therapy shows promise for tough lupus cases

Disease control Ongoing

This early-stage study tests a new treatment called AB-101 for people with lupus nephritis or other hard-to-treat lupus. AB-101 uses donated natural killer cells to boost the body's ability to fight the disease. The study aims to see if this approach is safe and can help patients…

Matched conditions: LUPUS NEPHRITIS - WHO CLASS IV

Phase 1 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

Lupus nephritis - who class IV

Get alerted when new Lupus nephritis - who class IV trials appear

Immune cell therapy shows promise for tough lupus cases